Makers Laboratories (BOM:506919) Long-Term Debt: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506919 Makers Laboratories Ltd BOM:506919
67 GF Score
Price ₹195.75
GF Value ₹182.26
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Makers Laboratories Long-Term Debt?

Makers Laboratories BOM:506919 -5.04% 67 Long-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:506919 with a GF Score™ of 67/100 and a GF Value™ of ₹182.26 (Fairly Valued). The stock has 5 warning signs investors should review.

Makers Laboratories's Long-Term Debt for the quarter that ended in Jun. 2026 was ₹0 Mil.

Makers Laboratories's quarterly Long-Term Debt increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹10 Mil) but then declined from Mar. 2026 (₹10 Mil) to Jun. 2026 (₹0 Mil).

Makers Laboratories's annual Long-Term Debt declined from Mar. 2024 (₹91 Mil) to Mar. 2025 (₹21 Mil) and declined from Mar. 2025 (₹21 Mil) to Mar. 2026 (₹10 Mil).

Makers Laboratories  (BOM:506919) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Makers Laboratories Long-Term Debt Related Terms

Makers Laboratories Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Makers Laboratories's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Makers Laboratories Long-Term Debt Chart

Makers Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.87 43.18 90.85 20.57 10.29

Makers Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 15.43 0.00 10.29 0.00
BOM:506919
67GF Score
Makers Laboratories Ltd BOM:506919
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹0 Mil mean?
Makers Laboratories (BOM:506919) has a Long-Term Debt of ₹0 Mil as of Jun. 2026.
Is Makers Laboratories' Long-Term Debt too high?
Makers Laboratories' current Long-Term Debt is ₹0 Mil. Overall, Makers Laboratories has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Makers Laboratories' Long-Term Debt compare to ZTS?
Makers Laboratories' Long-Term Debt of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Makers Laboratories's current Long-Term Debt is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Makers Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Makers Laboratories (BOM:506919) is currently considered Fairly Valued. The stock's GF Value™ is ₹182.26, compared to a current price of ₹195.75 — trading 7.4% above its estimated fair value. The current Long-Term Debt is ₹0 Mil. Makers Laboratories' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Makers Laboratories (BOM:506919), the current Long-Term Debt is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Makers Laboratories (BOM:506919) Overvalued in 2026?

Based on GuruFocus' analysis, Makers Laboratories stock appears to be overvalued. The current stock price of ₹195.75 is trading 7.4% above its estimated GF Value™ of ₹182.26. GuruFocus considers Makers Laboratories to be Fairly Valued.

Key valuation signals for BOM:506919:

  • Long-Term Debt: ₹0 Mil
  • GF Value™: ₹182.26 vs. price of ₹195.75 (7.4% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the BOM:506919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Makers Laboratories Business Description

Other Exchanges MAKERSL:India
Address 54-D, Kandivli Industrial Estate, Charkop, Kandivali (West), Mumbai, MH, IND, 400067
Makers Laboratories Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical products. The company's product portfolio includes Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough Range), and Exylin (Amoxycillin range), among others. The reportable segment of the company is the Pharmaceutical segment.
67GF Score

Get the complete analysis for BOM:506919

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹195.75
Price
₹182.26
GF Value